Catching cancer with carbon nanotubes
New device to test blood can spot cancer cells, HIV on the fly
New device to test blood can spot cancer cells, HIV on the fly
Engineers devise a new way to inspect advanced materials used to build airplanes
New 3-D microfluidic system offers greater control over production of drug-delivering nanoparticles.
New MIT nanoparticles could lead to powerful vaccines for HIV and other diseases.
Tiny 'microworms' could be implanted under the skin to give readout of blood sugar levels or other biomedical information.
New implantable sensor finds telltale signs; technology could also be adapted to monitor cancer and other diseases.
The new nanoparticle, which delivers the drug in a form activated when it reaches its target, also treats tumors more effectively than the unadorned drug in mice.
In white paper, MIT scientists discuss potential for revolutionary advances in biomedicine and other fields.
Honored for work on fluids with low global warming potential
Cancer scientists believe nanoparticles could accurately target tumors, avoiding side effects.
Study suggests new way for manufacturers to minimize environmental impact of carbon nanotube production
Particles can deliver a combination of chemotherapy drugs directly to prostate-cancer cells.
Project aims to create nanotechnology solutions for heart, lung and blood diseases.